Pricing Log in Create free account

MaxCyte, Inc. (MXCT) vs Nyxoah SA (NYXH)

MaxCyte, Inc. and Nyxoah SA are both Medical Devices companies. MaxCyte, Inc. is the larger, with a market value of $113.6M against $91.7M — 1.2× the size. Nyxoah SA grew revenue faster over the last twelve months: 443.7% against −0.13%. MaxCyte, Inc. has the higher net margin (−81.4% vs −318.4%) and the higher return on invested capital (−42.4% vs −118.6%). Across the 18 metrics below, MaxCyte, Inc. leads on 14 and Nyxoah SA on 4.

Valuation

Metric MXCT NYXH Medical Devices median
P/E n/m n/m 24.54
P/S 3.52 2.71 2.66
P/B 0.80 1.16 2.49
Price to free cash flow n/m n/m 27.07
EV/EBITDA n/m n/m 11.90
EV/Sales 0.72 1.90 2.50
Earnings yield (21.88%) (220.39%) (12.52%)
Free cash flow yield (17.71%) (96.91%) (8.59%)

Profitability

Metric MXCT NYXH Medical Devices median
Gross margin 80.98% 61.06% 58.51%
Operating margin (97.99%) (288.33%) (14.88%)
Net margin (81.40%) (318.36%) (14.45%)
Free cash flow margin (62.40%) (262.91%) (5.98%)
Return on equity (16.90%) (158.70%) (16.90%)
Return on assets (14.13%) (77.73%) (17.16%)
Return on invested capital (42.40%) (118.55%) (7.11%)

Growth

Metric MXCT NYXH Medical Devices median
Revenue growth (TTM) (0.13%) 443.69% 9.89%
EPS growth (last fiscal year) (7.69%) (36.22%) 28.17%
Revenue growth, 5-year CAGR 4.76% 170.14% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MXCT NYXH Medical Devices median
Debt to equity 0.00 0.78 0.04
Current ratio 7.83 2.19 2.78
Net debt to EBITDA 2.21 0.08 0.54

Dividend

Metric MXCT NYXH Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric MXCT NYXH Medical Devices median
Market cap 113.58m 91.66m 221.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack